Natriuretic Peptides—New Targets for Neurocontrol of Blood Pressure via Baroreflex Afferent Pathway
Natriuretic peptides (NPs) induce vasodilation, natriuresis, and diuresis, counteract the renin–angiotensin–aldosterone system and autonomic nervous system, and are key regulators of cardiovascular volume and pressure homeostasis. Baroreflex afferent pathway is an important reflex loop in the neuror...
Main Authors: | Xinyu Li, Yali Cui, Qing Zhang, Qingyuan Li, Mengxing Cheng, Jie Sun, Changpeng Cui, Xiongxiong Fan, Baiyan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/21/13619 |
Similar Items
-
The unpredictability of labile blood pressure: Afferent baroreflex failure in a critical patient with multiple thyroid surgeries and COVID-19 infection
by: Anas Mahmoud, MD, et al.
Published: (2023-02-01) -
GENDER AND AGE DIFFERENCES OF BRAIN NATRIURETIC PEPTIDE CONCENTRATION IN PATIENTS WITH MYOCARDIAL INFARCTION
by: E. N. Usoltseva, et al.
Published: (2014-07-01) -
Natriuretic peptides: Diagnostic and therapeutic use
by: Kaushik Pandit, et al.
Published: (2011-01-01) -
From Snake Venoms to Therapeutics: A Focus on Natriuretic Peptides
by: Wei Fong Ang, et al.
Published: (2022-09-01) -
Modified natriuretic peptides and their potential roles in cancer treatment
by: Mengjiao Xu, et al.
Published: (2022-02-01)